These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8206752)

  • 21. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
    Christmas SE; Meager A; Moore M
    Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysis of autologous tumor cells by high-density lymphocytes is potentiated by the streptococcal preparation OK432 (Picibanil).
    Vánky F; Uchida A; Klein E; Willems J
    Int J Cancer; 1986 Apr; 37(4):531-6. PubMed ID: 3082771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of tumor cell susceptibility to lymphokine-activated killer cells by treatment with the streptococcal preparation OK432.
    Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Tamai M; Noguchi K; Hotta T; Arii K
    Biotherapy; 1992; 5(1):83-93. PubMed ID: 1389905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hepatic metastasis of colon carcinoma by asialo GM1--positive cells in the liver.
    Shiratori Y; Nakata R; Okano K; Komatsu Y; Shiina S; Kawase T; Sugimoto T; Omata M; Tanaka M
    Hepatology; 1992 Aug; 16(2):469-78. PubMed ID: 1639356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factors.
    Uchida A; Klein E
    Immunol Lett; 1985; 10(3-4):177-81. PubMed ID: 3899922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
    Uchida A; Micksche M
    J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive effects of OK432 on murine acute myocarditis due to encephalomyocarditis virus.
    Yokoyama T; Kanda T; Suzuki T; Murata K
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):471-80. PubMed ID: 1713056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The augmenting effect of OK432-stimulated B cells on the in vitro generation of anti-tumor cytotoxic T lymphocytes from tumor-draining lymph node cells: the possible role of interleukin-12.
    Shinomiya Y; Harada M; Tamada K; Kurosawa S; Okamoto T; Terao H; Takenoyama M; Ito O; Hirashima C; Li T; Shirakusa T; Nomoto K
    In Vivo; 1997; 11(1):1-8. PubMed ID: 9067765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.
    Oswald IP; Wynn TA; Sher A; James SL
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8676-80. PubMed ID: 1528880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
    Chen L; Suzuki Y; Wheelock EF
    J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Augmentation of cytotoxicity of tumor infiltrating lymphocytes by interleukin-2 in gastric cancer patients].
    Gotoh K
    Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1600-7. PubMed ID: 3878935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the hepatoma cell injury by antibody-dependent cell-mediated cytotoxicity and its augmentation by pretreatment of macrophages with OK432].
    Mizoguchi Y; Tsutsui H; Yamamoto S; Morisawa S
    Arerugi; 1984 Mar; 33(3):135-41. PubMed ID: 6466102
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC.
    Haranaka R; Hasegawa R; Nakagawa S; Sakurai A; Satomi N; Haranaka K
    J Biol Response Mod; 1988 Feb; 7(1):77-90. PubMed ID: 3131489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions.
    Miyahara E; Yamaguchi Y; Hihara J; Noma K; Toge T
    J Exp Ther Oncol; 1996 Jul; 1(4):242-50. PubMed ID: 9414411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activity of Enterococcus faecalis (FK-23) preparation as a biological response modifier].
    Ohasi K; Ueda H; Yamazaki M; Kimura S; Abe S; Yamaguchi H
    Yakugaku Zasshi; 1992 Dec; 112(12):919-25. PubMed ID: 1294717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intratumoral administration of OK432 in rats with liver tumor].
    Ishimaru M
    Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):880-8. PubMed ID: 2972906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-derived recognition factor (TDRF) induces production of TNF-alpha by murine macrophages, but requires synergy with IFN-gamma alone or in combination with IL-2 to induce nitric oxide synthase.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    Int J Immunopharmacol; 1996; 18(8-9):479-90. PubMed ID: 9023587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological response modifier as antigen: OK432-specific T-cell clone as an anti-tumor effector cell.
    Ozaki S; Suginoshita T
    Cell Immunol; 1989 May; 120(2):477-81. PubMed ID: 2785863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K; Mihich E; Ehrke MJ
    Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of OK432 and human interferon-alpha for treating viral-induced diabetes mellitus in mice.
    Kanda T; Kogure S; Nara M; Tsukui S; Utsugi T; Tomono S; Kawazu S; Nagai R; Kobayashi I
    Eur J Pharmacol; 1998 Jan; 342(2-3):297-302. PubMed ID: 9548400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.